U.S. FDA approves Shire's Vyvanse for binge-eating disorder
January 30, 2015 at 16:46 PM EST
WASHINGTON, Jan 30 (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.
